BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27053879)

  • 1. Treatment of cancerous ascites and radical gastrectomy with intraperitoneal hyperthermic double-distilled water and cis-diaminodichloro-platinum perfusion.
    Chen ZX; Chen JP; Chen Z; Peng DS; Zhen JX; Tan JS
    World J Gastroenterol; 1997 Dec; 3(4):246-8. PubMed ID: 27053879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inhibitory effect of intraperitoneal hyperthermic and hypotonic chemotherapy on ascites cancer cells in mice].
    Chen Z; Peng D; Tan J
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):101-4. PubMed ID: 7657323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Curative effect of radical gastrectomy combined with peritoneal lavage with thermal hypoosmotic solution in treatment of gastric cancer].
    Chen J; Wang S; Xu H
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):730-2. PubMed ID: 11798956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of intraperitoneal hyperthermic perfusion in far-advanced gastric cancer].
    Kiuchi S; Fujimoto S; Shrestha RD; Kokubun M; Kobayashi K; Konno C; Takahashi M; Okui K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2726-9. PubMed ID: 2506818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2331-4. PubMed ID: 3136703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer.
    Cui HB; Ge HE; Bai XY; Zhang W; Zhang YY; Wang J; Li X; Xing LP; Guo SH; Wang ZY
    Exp Ther Med; 2014 May; 7(5):1083-1088. PubMed ID: 24940391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
    Sugiyama Y; Suzuki H; Hada R; Miyagishima K; Yokoyama M; Daidouji K; Murata A; Yamazaki S; Mikami Y; Ozawa M
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):619-24. PubMed ID: 1901477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
    Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
    Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
    Yang XJ; Li Y; Yonemura Y
    J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer.
    Zhang T; Pan Q; Xiao S; Li L; Xue M
    Oncol Lett; 2016 May; 11(5):3287-3292. PubMed ID: 27123104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer].
    Zhang GY; Chen XC; Pan K; Xia LG; Zuo M; Zheng T
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):362-4. PubMed ID: 17659464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
    Huang O; Lu X; Xu X; Shi Y
    Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug.
    Koga S; Hamazoe R; Maeta M; Shimizu N; Kanayama H; Osaki Y
    Cancer Res; 1984 May; 44(5):1840-2. PubMed ID: 6424932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.
    Li C; Yan M; Chen J; Xiang M; Zhu ZG; Yin HR; Lin YZ
    J Surg Oncol; 2010 Oct; 102(5):361-5. PubMed ID: 20872942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
    Cui S; Ba M; Tang Y; Liu J; Wu Y; Wang B; Zhang X; Tang H; Zhong S
    Oncol Rep; 2012 Oct; 28(4):1325-31. PubMed ID: 22797826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The growth-inhibiting effects of hyperthermic-hypoosmotic solution alone and in combination with chemotherapeutic agents on human gastric cancer xenograft in mice].
    Xu H; Chen J; He S
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):270-3. PubMed ID: 11038756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.